The latest price target for Applied Therapeutics (NASDAQ:APLT) was reported by Citigroup on September 19, 2024. The analyst firm set a price target for $11.00 expecting APLT to rise to within 12 months (a possible 41.57% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Applied Therapeutics (NASDAQ:APLT) was provided by Citigroup, and Applied Therapeutics maintained their buy rating.

There is no last upgrade for Applied Therapeutics

The last downgrade for Applied Therapeutics Inc happened on January 4, 2022 when Barclays changed their price target from $44 to $7 for Applied Therapeutics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Applied Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Applied Therapeutics was filed on September 19, 2024 so you should expect the next rating to be made available sometime around September 19, 2025.

While ratings are subjective and will change, the latest Applied Therapeutics (APLT) rating was a maintained with a price target of $8.00 to $11.00. The current price Applied Therapeutics (APLT) is trading at is $7.77, which is out of the analyst’s predicted range.